These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27239517)

  • 1. Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios.
    Marelli C; Gutierrez LA; Menjot de Champfleur N; Charroud C; De Verbizier D; Touchon J; Douillet P; Berr C; Lehmann S; Gabelle A
    Alzheimers Dement (Amst); 2015 Sep; 1(3):371-9. PubMed ID: 27239517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.
    Baldeiras I; Santana I; Leitão MJ; Ribeiro MH; Pascoal R; Duro D; Lemos R; Santiago B; Almeida MR; Oliveira CR
    J Neurol Sci; 2015 Nov; 358(1-2):308-16. PubMed ID: 26388316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
    Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
    J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
    Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
    Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes.
    Pijnenburg YA; Verwey NA; van der Flier WM; Scheltens P; Teunissen CE
    Alzheimers Dement (Amst); 2015 Dec; 1(4):505-12. PubMed ID: 27239528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
    Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
    Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration.
    Cousins KAQ; Phillips JS; Irwin DJ; Lee EB; Wolk DA; Shaw LM; Zetterberg H; Blennow K; Burke SE; Kinney NG; Gibbons GS; McMillan CT; Trojanowski JQ; Grossman M
    Alzheimers Dement; 2021 May; 17(5):822-830. PubMed ID: 33226735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No added diagnostic value of non-phosphorylated tau fraction (p-tau
    Goossens J; Bjerke M; Struyfs H; Niemantsverdriet E; Somers C; Van den Bossche T; Van Mossevelde S; De Vil B; Sieben A; Martin JJ; Cras P; Goeman J; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
    Alzheimers Res Ther; 2017 Jul; 9(1):49. PubMed ID: 28709448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.
    Oeckl P; Steinacker P; Feneberg E; Otto M
    J Neurochem; 2016 Aug; 138 Suppl 1():184-92. PubMed ID: 27186717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes.
    Valotassiou V; Papatriantafyllou J; Sifakis N; Tzavara C; Tsougos I; Kapsalaki E; Hadjigeorgiou G; Georgoulias P
    Nucl Med Commun; 2012 Dec; 33(12):1267-76. PubMed ID: 23018627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer's disease: evidence from the Frontal Behavioral Inventory.
    Konstantinopoulou E; Aretouli E; Ioannidis P; Karacostas D; Kosmidis MH
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):939-46. PubMed ID: 23135894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.
    Rivero-Santana A; Ferreira D; Perestelo-Pérez L; Westman E; Wahlund LO; Sarría A; Serrano-Aguilar P
    J Alzheimers Dis; 2017; 55(2):625-644. PubMed ID: 27716663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD.
    Alcolea D; Irwin DJ; Illán-Gala I; Muñoz L; Clarimón J; McMillan CT; Fortea J; Blesa R; Lee EB; Trojanowski JQ; Grossman M; Lleó A
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):180-186. PubMed ID: 30297518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical accuracy of the distinction between Alzheimer's disease and frontotemporal lobar degeneration.
    Sutovsky S; Blaho A; Kollar B; Siarnik P; Csefalvay Z; Dragasek J; Turcani P
    Bratisl Lek Listy; 2014; 115(3):161-7. PubMed ID: 24579686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease.
    Irwin DJ; Trojanowski JQ; Grossman M
    Front Aging Neurosci; 2013; 5():6. PubMed ID: 23440936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the AT(N) and Other CSF Classification Systems in Behavioral Variant Frontotemporal Dementia.
    Constantinides VC; Boufidou F; Bourbouli M; Pyrgelis ES; Ghika A; Koros C; Liakakis G; Papageorgiou S; Stefanis L; Paraskevas GP; Kapaki E
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.